Applicant, as named in the Orange Book

Alcon Labs Inc

Next listed expiry: Simbrinza on 30 Oct 2030. 7 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Simbrinza brimonidine tartrate; brinzolamide	brimonidine tartrate; brinzolamide	204251	30 Oct 2030	patent
Pataday Once Daily Relief olopatadine hydrochloride	olopatadine hydrochloride	206276	19 May 2032	patent
Eysuvis loteprednol etabonate	loteprednol etabonate	210933	3 May 2033	patent
Inveltys loteprednol etabonate	loteprednol etabonate	210565	3 May 2033	patent
Rhopressa netarsudil mesylate	netarsudil mesylate	208254	14 Mar 2034	patent
Rocklatan latanoprost; netarsudil dimesylate	latanoprost; netarsudil dimesylate	208259	14 Mar 2034	patent
Tryptyr acoltremon	acoltremon	217370	16 Dec 2042	patent

Recent events

26 Oct 2026Isopto Atropine · Generic approved 16 Oct 2026
25 Oct 2026Pataday Once Daily Relief · Generic approved 6 Jan 2026

Products without listed protection (4)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Fluorescite fluorescein sodium	fluorescein sodium	021980	open now	no listed protection
Isopto Atropine atropine sulfate	atropine sulfate	208151	open now	no listed protection
Pataday Once Daily Relief olopatadine hydrochloride	olopatadine hydrochloride	021545	open now	no listed protection
Pataday Twice Daily Relief olopatadine hydrochloride	olopatadine hydrochloride	020688	open now	no listed protection